"Avoidable Deaths" - Union for International Cancer Control
"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group
"Bald for a Cause" initiative - UWC Dilijan College
New Paper Alert: TUXEDO-3 Trial Demonstrates Clinical Activity of Patritumab Deruxtecan in Leptomeningeal Metastases from Solid Tumors
Robin Zon: Applications for the 2026-27 ASCO Leadership Development Program Are Open
We Sincerely Thank and Deeply Appreciate OncoDaily's Support for Featuring Our Recent Conference - Medibridge Global Academy
Patrick Hwu: AntiPD1 in combination with antilag3 and ctla4 in head and neck cancers
Raffaele Colombo: Tisotumab vedotin as 2nd or 3rd line therapy for recurrent cervical cancer
Vivek Subbiah: The latest and greatest in cancer research in 2024
